Efficacy and tolerability of the pharmaconutraceutical complex Theraflex Ultra in the treatment of patients with chronic non-specific lower back pain due toprimarily discogenic pathology (FORSAGE study)

医学 耐受性 观察研究 生活质量(医疗保健) 背痛 腰痛 物理疗法 内科学 麻醉 临床疗效 伤害 评定量表 慢性疼痛 临床试验 疼痛控制 外科
作者
Igor N. Samartsev,С. А. Живолупов,M S Parshin,Yu.V. Denisova
出处
期刊:Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova [Media Sphera Publishing Group]
卷期号:126 (5): 108-108
标识
DOI:10.17116/jnevro2026126051108
摘要

Objective. To evaluate the efficacy and tolerability of the pharmaconutraceutical complex, Theraflex Ultra, based on undenatured (native) type II collagen, in the treatment of discogenic chronic low back pain (CLBP). Material and methods. This open, multicenter, observational study included 50 patients (28 women and 22 men; mean age 48.3 years [45.5; 52.2]) diagnosed with CLBP, mostly associated with discogenic pathology, as confirmed by clinical evaluation and neuroimaging. The study group (n=25) received standard therapy comprising non-steroidal anti-inflammatory drugs (NSAIDs) for 10 days, a centrally acting muscle relaxant for 14 days, and a high-dose vitamin B complex for 21 days, combined with Theraflex Ultra at 2 capsules twice daily for 2 months. The control group (n=25) received only the standard therapy. Efficacy was assessed after 1, 2, and 3 months using various scales, including the Numeric Rating Scale for Pain (NRS-P), the Douleur Neuropathique 4 (DN4), the Back Pain Functional Scale (BPFS), and the Medical Outcomes Study Short Form 36 (MOS SF-36). The relapse rate during the first year post-enrollment in the study was also documented. Results. After one month, the study group exhibited a significantly greater reduction in pain intensity, as measured by the NRS-P, compared to the control group (23.2±8.8 versus 35.2±7.4; p<0.05). After two months, the study group demonstrated significant improvements in functional activity (BPFS: 51.7±15.7 vs. 40.2±13.1) and the physical component of quality of life (MOS SF-36: 86.8±5.5 vs. 77.2±8.1; p<0.05). No intergroup differences were noted on the DN4 scale, indicating nociceptive pain. Treatment adherence in the study group was high, with a score of 9.9±4.2 on the Adherence to Refills and Medications Scale (ARMS-7). A relapse occurred in 20% of patients in the study group and 32% in the control group after one year (relative risk [RR] 1.4 [confidence interval [CI] 0.513-3.824]; number needed to treat [NNT]=8.3). Adverse events were reported in all groups; however, they were mild and did not require treatment discontinuation. Conclusion. The addition of Theraflex Ultra to the standard therapy regimen for discogenic chronic non-specific low back pain yields a significant reduction in pain intensity, enhanced functional activity and quality of life, and a decreased risk of relapse within a year. The product demonstrates high treatment adherence and favorable tolerability. Subsequent randomized studies are warranted to validate these findings.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Sushi发布了新的文献求助10
1秒前
xc发布了新的文献求助10
1秒前
2秒前
3秒前
谋勇兼备发布了新的文献求助100
3秒前
害羞白猫完成签到 ,获得积分10
3秒前
5秒前
史文韬发布了新的文献求助10
5秒前
6秒前
wency发布了新的文献求助10
7秒前
希望天下0贩的0的应助被Zhang采纳,获得10
9秒前
天天快乐的应助被双曲采纳,获得10
10秒前
Waitcy发布了新的文献求助10
10秒前
11秒前
YangL完成签到,获得积分10
11秒前
12秒前
Cancellerzz完成签到,获得积分10
12秒前
斯文败类的应助被我真不忙采纳,获得10
14秒前
14秒前
charon发布了新的文献求助10
15秒前
一颗葡萄完成签到 ,获得积分10
15秒前
15秒前
东风的应助被Wangyingjie5采纳,获得30
16秒前
111完成签到,获得积分10
16秒前
16秒前
焱焱不忘完成签到 ,获得积分0
16秒前
Bin完成签到,获得积分10
17秒前
郝磊完成签到 ,获得积分10
18秒前
Fairy完成签到 ,获得积分10
18秒前
史文韬发布了新的文献求助10
18秒前
d3211501051完成签到 ,获得积分10
18秒前
zzzzzz完成签到,获得积分10
18秒前
烟花的应助被XX采纳,获得20
18秒前
19秒前
橙子完成签到,获得积分10
20秒前
七颗茶香豆的应助被星星采纳,获得10
20秒前
小周发布了新的文献求助10
21秒前
玻璃弹珠完成签到,获得积分10
21秒前
Lucia发布了新的文献求助10
21秒前
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194332
求助须知:如何正确求助?哪些是违规求助? 9580146
关于积分的说明 21869842
捐赠科研通 7793919
什么是DOI,文献DOI怎么找? 3437579
关于科研通互助平台的介绍 2560986
邀请新用户注册赠送积分活动 2484371